AstraZeneca, NHS, Decorte panel on Future of AI in Healthcare

From Cambridge Judge Business School:

Heavy rain didn't stop over 200 curious #entrepreneurs from turning up to our #EnterpriseTuesday session on 13 Feb 2024 at Cambridge Judge Business School. We discussed how far #artificialintelligence (AI) could take us in the future of healthcare and the critical success factors that need to be in place for these opportunities to be realised. A big thank you to all our panellists, Dr David Weston (AstraZeneca), Vincenzo Garzya (AstraZeneca), Dr Roeland P.-J. E. Decorte (Decorte Future Industries), Dr Emily Faulkner (NHS Innovation, Cambridgeshire and Peterborough) and Hannah Sore (PharmEnable) for their time, knowledge and expertise.

Key Takeways:
- The importance of #ethics and #governance frameworks to be in place
- The complexity of #data and access
- The value of innovation integrating AI around #patientcentricity

Previous
Previous

Decorte, Stability AI, Microsoft panel on Generative AI

Next
Next

Decorte Health Tech World Podcast interview